Literature DB >> 10444184

Enhanced adherence of beta-thalassaemic erythrocytes to endothelial cells.

T Hovav1, A Goldfarb, G Artmann, S Yedgar, G Barshtein.   

Abstract

The adherence of red blood cells (RBC) to endothelial cells (EC), shown to correlate with microvascular occlusion in sickle cell disease and malaria, is considered a major contributor to microcirculatory disorders. In the present study the adherence to EC was markedly enhanced with RBC from beta-thalassaemia major (TM) patients, and even more so with RBC from beta-thalassaemia intermedia (TI) patients (10-fold and 25-fold higher than normal, respectively). It is proposed that enhanced RBC/EC adherence may contribute to the microcirculatory disorders observed in thalassaemia, especially in TI patients who are particularly known to suffer from leg ulcers.

Entities:  

Mesh:

Year:  1999        PMID: 10444184     DOI: 10.1046/j.1365-2141.1999.01489.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

3.  Properties of stored red blood cells: understanding immune and vascular reactivity.

Authors:  Philip C Spinella; Rosemary L Sparrow; John R Hess; Philip J Norris
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

4.  Thrombin Activable Fibrinolysis Inhibitor in Beta Thalassemia.

Authors:  Aruna Chhikara; Sunita Sharma; Jagdish Chandra; Anita Nangia
Journal:  Indian J Pediatr       Date:  2016-08-03       Impact factor: 1.967

Review 5.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

6.  Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders.

Authors:  Vichai Atichartakarn; Khanchit Likittanasombat; Suporn Chuncharunee; Pakorn Chandanamattha; Surapon Worapongpaiboon; Pantep Angchaisuksiri; Katcharin Aryurachai
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.490

7.  Coagulopathy in Beta-thalassemia: current understanding and future perspectives.

Authors:  M Domenica Cappellini; Khaled M Musallam; Alessia Marcon; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-29       Impact factor: 2.576

8.  Thalassemia and venous thromboembolism.

Authors:  Julien Succar; Khaled M Musallam; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-25       Impact factor: 2.576

9.  Vascular endothelial dysfunction in β-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NO.

Authors:  Ekatherina Stoyanova; Marie Trudel; Hady Felfly; Wafaa Lemsaddek; Damien Garcia; Guy Cloutier
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

Review 10.  Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.

Authors:  Francesca Vinchi; Emanuela Tolosano
Journal:  Oxid Med Cell Longev       Date:  2013-05-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.